CAD 3.73
(-3.37%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 76.93 Million | -133.01 Million | 19.81 Million | 134.53 Million | 85.78 Million | 110.27 Million |
Net Income | -62.35 Million | 135.96 Million | -31.62 Million | -43.4 Million | -10.45 Million | -444.34 Million |
Depreciation & Amortization | 69.5 Million | 71.21 Million | 84.18 Million | 98.08 Million | 95.78 Million | 50.4 Million |
Deferred income taxes | -14.57 Million | -5.37 Million | 67.53 Million | 48.93 Million | 12.78 Million | -53.82 Million |
Stock-based compensation | - | 446 Thousand | 49 Thousand | 135 Thousand | 333 Thousand | 158 Thousand |
Change in working capital | 86.59 Million | -42.07 Million | -26.4 Million | 5.75 Million | -21.15 Million | 31.85 Million |
Other non-cash items | 22.74 Million | -293.18 Million | -73.92 Million | 25.02 Million | 8.48 Million | 526.01 Million |
Investing Cash Flow | -20.53 Million | 734.89 Million | 14.14 Million | -27.26 Million | -32.37 Million | -54.14 Million |
Investments in PPE | -23.55 Million | -27.64 Million | -36.26 Million | -33.71 Million | -38.01 Million | -54.54 Million |
Acquisitions | - | 44.1 Million | 44.1 Million | -162 Thousand | -162 Thousand | -2.95 Million |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | 3.01 Million | 718.43 Million | 6.3 Million | 6.61 Million | 5.79 Million | 3.35 Million |
Financing Cash Flow | -65.95 Million | -608.38 Million | -23.69 Million | -109.8 Million | -54.71 Million | -52.26 Million |
Debt repayment | -59.34 Million | -217.59 Million | -346.92 Million | -116.2 Million | -206 Million | -29.82 Million |
Dividends payments | - | -390.64 Million | - | -14.59 Million | -14.59 Million | -38.92 Million |
Common Stock Repurchased | - | -499 Thousand | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -6.6 Million | 354 Thousand | 323.23 Million | 21 Million | 165.89 Million | 16.48 Million |
Accounts receivables | -2.99 Million | 71.06 Million | 5.59 Million | -48.13 Million | 324 Thousand | -4.34 Million |
Accounts payables | 35.12 Million | - | 126.03 Million | -31.18 Million | -23.65 Million | 102.93 Million |
Inventory | 62.5 Million | -63.15 Million | -158.73 Million | 94.25 Million | -4.97 Million | -60.32 Million |
Other working capital | -8.04 Million | -49.99 Million | 709 Thousand | -9.17 Million | 7.15 Million | -6.41 Million |
Cash at beginning of period | 32.4 Million | 52.16 Million | 38.23 Million | 39.14 Million | 39.27 Million | 36.84 Million |
Cash at end of period | 24.08 Million | 32.4 Million | 52.16 Million | 38.23 Million | 39.14 Million | 39.27 Million |
Capital Expenditure | -23.55 Million | -27.64 Million | -36.26 Million | -33.71 Million | -38.01 Million | -54.54 Million |
Effect of forex changes on cash | 1.23 Million | -13.25 Million | 3.66 Million | 1.62 Million | 1.17 Million | -1.43 Million |
Net cash flow / Change in cash | -8.32 Million | -19.75 Million | 13.93 Million | -906 Thousand | -131 Thousand | 2.43 Million |
Free Cash Flow | 53.38 Million | -160.65 Million | -16.45 Million | 100.82 Million | 47.77 Million | 55.72 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -59.48 Million | -17.56 Million | -3.75 Million | -62.35 Million | -10.36 Million | -16.72 Million |
Depreciation & Amortization | 17.3 Million | 17.07 Million | 16.74 Million | 69.5 Million | 17.44 Million | 17.5 Million |
Deferred income taxes | 606 Thousand | 835 Thousand | -9.62 Million | -14.57 Million | 185 Thousand | -2.36 Million |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -7.74 Million | 1.1 Million | 9.19 Million | 86.59 Million | 10.14 Million | 14.61 Million |
Other non-cash items | 12.59 Million | 5.81 Million | 3.98 Million | 22.74 Million | 6.46 Million | 6.05 Million |
Investing Cash Flow | -2.07 Million | -3.27 Million | -9.3 Million | -20.53 Million | -3.35 Million | -1.45 Million |
Investments in PPE | -4.58 Million | -6.5 Million | -9.32 Million | -23.55 Million | -3.36 Million | -4.43 Million |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | 272 Thousand | 728 Thousand | 19 Thousand | 3.01 Million | 6000.00 | 2.97 Million |
Financing Cash Flow | -3.35 Million | 4.74 Million | -7.75 Million | -65.95 Million | -8.9 Million | -17.09 Million |
Debt repayment | -3.18 Million | -5.42 Million | -30.41 Million | -59.34 Million | -9.46 Million | -9.63 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -159 Thousand | -681 Thousand | 22.66 Million | -6.6 Million | 565 Thousand | -7.46 Million |
Accounts receivables | -25.47 Million | -1.69 Million | 4.79 Million | -2.99 Million | -4.17 Million | -23.55 Million |
Accounts payables | - | - | 8.64 Million | 35.12 Million | 7.82 Million | 37.1 Million |
Inventory | 11.27 Million | 27.4 Million | -2.92 Million | 62.5 Million | 10.63 Million | 3.79 Million |
Other working capital | -1.43 Million | 326 Thousand | -1.31 Million | -8.04 Million | -4.14 Million | -2.72 Million |
Cash at beginning of period | 25.5 Million | 24.08 Million | 24.55 Million | 32.4 Million | 24.1 Million | 29.07 Million |
Cash at end of period | 22.12 Million | 25.5 Million | 24.08 Million | 24.08 Million | 24.55 Million | 24.1 Million |
Capital Expenditure | -4.58 Million | -6.5 Million | -9.32 Million | -23.55 Million | -3.36 Million | -4.43 Million |
Effect of forex changes on cash | -1.09 Million | -116 Thousand | 1.76 Million | 1.23 Million | 124 Thousand | 1.05 Million |
Net cash flow / Change in cash | -3.37 Million | 1.41 Million | -467 Thousand | -8.32 Million | 455 Thousand | -4.97 Million |
Free Cash Flow | -1.44 Million | -6.44 Million | 5.49 Million | 53.38 Million | 9.22 Million | 8.08 Million |
PDS
HYPMY
0697
FSTR
TOP-R
BALPHARMA